To view this email as a web page, click here.

 
IOL Advances
 
Applying novel IOL technology in battle against dry AMD
Andreas F. Borkenstein, MD, discusses a novel IOL device uniquely tailored for patients with dry AMD.
Learn more
 
ADVERTISEMENT
 
Alcon debuts novel trifocal IOL to U.S. market
image description here With FDA approval in hand, Alcon has kicked off the initial commercial launch of the AcrySof IQ PanOptix Trifocal IOL, the first and only trifocal lens for U.S. patients undergoing cataract surgery.

Find out
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.